Acute immunodeficiency, multiple organ injury, and the pathogenesis of SARS.
Jiang Gu,C. Taylor
DOI: https://doi.org/10.1097/00129039-200312000-00001
2003-12-01
Abstract:Severe acute respiratory syndrome (SARS) originated in Guangdong province, China, in November 2002 and quickly spread throughout the world. It then virtually disappeared from the Earth in August 2003, just like it first appeared about 9 months earlier, quite suddenly and mysteriously. When the deadly epidemic was over, more than 8000 victims had been infected and over 800 had died. Beijing was the worst hit area of this disease. The economic damage of SARS has been estimated by some to be at least 10 times greater than that of the 9/11 terrorist attacks, and the fear of its recurrence lingers in the minds of medical professionals worldwide. The longterm consequences of this epidemic are still being assessed. To respond to the challenge of this major epidemic, an international symposium on the pathogenesis of SARS was conducted at Peking (Beijing) University on July 12th and 13th, 2003. About 130 original research articles were submitted, including 40 platform presentations. Molecular morphology and immunohistochemistry played a crucial role in many of the reported studies. We are pleased to announce that the Proceedings of this symposium are being published by AIMM in two issues (the current issue, 11#4, 2003, and the next issue, 12#1, 2004). The abstracts are divided into four categories: Pathology, Immunology, Molecular Biology, and Clinical Features. The first three parts, consisting of some 60 abstracts, are published in this issue of AIMM; the remaining category will be published in the next issue. While detailed reports of the research and clinical data of SARS will undoubtedly appear in various medical journals in the coming months and years, the publication of the Proceedings in AIMM serves as a rapid and comprehensive reflection of the original knowledge gained by those medical scientists who found themselves at the frontier of the original outbreak. The goal is to accelerate the dissemination of knowledge and hence promote understanding of this disease. This symposium had a number of unique features. First, it was very timely, in that it was held when the deadly SARS epidemic had begun to subside, but was not completely over. While the proceedings were ongoing in the Conference Center of Peking University, a few dozen SARS patients were still being treated in the hospitals nearby, and the threat of the epidemic was still very real worldwide. Second, the papers reported at the conference represented the first batch of original clinical and research data derived from this epidemic. The originality and the quantity of information presented about this new disease were overwhelmingly reassuring, and served to inspire confidence at a time when international and public opinion sometimes bordered on hysteria. If the epidemic ever resurges, as many experts expect, the data presented at this conference will be extremely valuable, as the urgency for understanding and controlling this disease would again assume high priority for the medical community. Even if the epidemic never comes back, as we all hope, the data presented at this symposium will be a unique source of original data for scientists to study and return to in the future. Third, this conference was held in Beijing where people saw the most severe medical and social consequences of this new disease. The papers presented at this conference were submitted by frontline physicians who directly cared for the patients, and by scientists who were involved in studying this disease from the very beginning. Many risked their lives to obtain research data. Their heroic efforts were a part of what will be seen as a historical battle against SARS in China. In short, the data presented at this conference were profoundly valuable to those present, and should be shared by the scientific community worldwide. It so happened that one of the Co-editors-in-Chief (JG) of AIMM was the organizer of this symposium. He was also the Dean of the School of Basic Medical Sciences at Peking University and the Principal Investigator of a major project to study the pathogenesis of SARS. It is only natural that AIMM should bring this wealth of original information about SARS to its readers. Most importantly, through careful reading of the presented data of the Proceedings, a clearer picture of the clinical features and the pathogenesis of SARS begins to emerge. Detailed investigations of the world’s largest series of SARS autopsies, and in-depth analysis of the most extensive collection of SARS clinical data, have yielded a number of significant advances in our understanding of this disease. For example, it is now clear that SARS is not only a disease of the lungs, as had been commonly accepted by the medical community and the world at large; it is in fact most critically a disease of the immune system, of which the pulmonary lesions are a Applied Immunohistochemistry & Molecular Morphology 11(4): 281–282, 2003 © 2003 Lippincott Williams & Wilkins, Inc., Philadelphia